SOP Guide for Pharma

Capsule: SOP for Dissolution Testing of Capsules – V 2.0

Auditor

Capsule: SOP for Dissolution Testing of Capsules – V 2.0

Standard Operating Procedure for Dissolution Testing of Capsules

Department Capsule Manufacturing
SOP No. SOP/CM/189/2025
Supersedes SOP/CM/189/2022
Page No. Page 1 of 9
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

This SOP defines the procedure for performing dissolution testing of capsules to ensure that the release of active pharmaceutical ingredients (APIs) from capsules meets the required specifications under defined conditions.

2. Scope

This SOP applies to all soft and hard gelatin capsules that require dissolution testing to verify that the capsules release the drug substance in a controlled and predictable manner.

3. Responsibilities

4. Accountability

The QA Manager is responsible for ensuring that the dissolution testing process adheres to regulatory and company standards. The QC Supervisor is responsible for the execution of dissolution testing and ensuring that the results are accurate and compliant with specifications. The Production Supervisor ensures that the required samples are provided for testing in a timely manner.

See also  Capsule: SOP for Validation of Capsule Packing Processes - V 2.0

5. Procedure

5.1 Pre-Testing Setup

Before starting the dissolution test, ensure the following:

  1. Review Testing Criteria
    1. Review the dissolution specifications for the capsules based on the regulatory guidelines (e.g., USP, EP). These limits must be approved by the QA department before testing.
  2. Prepare Testing Equipment
    1. Ensure the dissolution apparatus is calibrated and the temperature of the dissolution medium is maintained at 37°C ± 0.5°C.
    2. Ensure that all dissolution equipment, such as paddles or baskets, are in good condition and properly installed.
  3. Prepare Sample Collection
    1. Collect a representative sample of capsules, typically 6 capsules, from the batch. The sample should be selected randomly to ensure it is representative of the entire batch.

5.2 Dissolution Testing Procedure

Follow these steps to perform the dissolution test:

  1. Prepare Dissolution Apparatus
    1. Place the appropriate number of capsules (typically 6 capsules) in the dissolution apparatus, ensuring they are correctly positioned and the medium volume is correct (usually 900 mL of the dissolution medium).
  2. Initiate Testing
    1. Set the dissolution apparatus to the appropriate speed, typically 50-75 rpm, and begin the test. The dissolution medium should maintain the specified temperature (37°C ± 0.5°C).
  3. Monitor Dissolution Process
    1. At specified time intervals, withdraw samples of the dissolution medium, typically at 15, 30, 45, and 60 minutes, and analyze for the released API.
  4. Document Results
    1. Record the cumulative percentage of drug released at each time interval. Compare the results with the acceptance criteria (e.g., 80% API release in 30 minutes).
See also  Capsule: SOP for Cleaning Sieves and Screens in Capsule Production - V 2.0

5.3 Post-Testing Activities

After the dissolution test is completed, ensure the following:

  1. Review Results
    1. The QA Manager reviews the dissolution test results to ensure that the capsules meet the specified release criteria. If any capsule fails to meet the specifications, initiate an investigation.
  2. Corrective Actions
    1. If any capsule fails the dissolution test, the root cause should be investigated, which could include reviewing the formulation, the manufacturing process, or the quality of raw materials used. Appropriate corrective actions should be implemented.
  3. Training and Feedback
    1. If discrepancies are identified during testing, provide feedback to operators and provide training as necessary to ensure correct procedures are followed.
  4. Record Keeping
    1. Ensure that all records related to dissolution testing, including the test logs, results, and corrective actions, are properly filed and archived in compliance with regulatory requirements.

6. Abbreviations

See also  Capsule: SOP for Use of Personal Protective Equipment in Dispensing Areas - V 2.0

7. Documents

  1. Annexure 1: Equipment Calibration Log
  2. Annexure 2: Dissolution Testing Log
  3. Annexure 3: Corrective Action Report

8. References

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure 1: Equipment Calibration Log

Equipment ID Calibration Date Operator Calibration Details Next Calibration Due
Dissolution Apparatus 105 01/02/2025 John Doe Calibration of dissolution speed and temperature 01/02/2026

Annexure 2: Dissolution Testing Log

Capsule ID Test Date Test Time (min) Release (%) Acceptance Criteria Result
Batch 003 02/02/2025 30 95% ≥ 85% released in 30 minutes Pass

Annexure 3: Corrective Action Report

Batch ID Deviation Corrective Action Responsible Person Completion Date
Batch 003 API release failure Adjustment of capsule filling process Production Supervisor 03/02/2025

12. Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial version of SOP Creation of SOP for dissolution testing of capsules QA Head
01/02/2025 2.0 Updated dissolution method and record format Improved testing procedure and compliance QA Head
Exit mobile version